You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Solid Tumor and Non Hodgkin Lymphoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor, Refractory Non-Hodgkin Lymphoma Trial (HCB101)

Not yet recruiting
  • Advanced Solid Tumor
  • Refractory Non-Hodgkin Lymphoma
  • (no location specified)
May 28, 2023

Glioblastoma, Squamous Cell Carcinoma, Hodgkin Lymphoma Trial (AVM0703, Hydrocortisone, Proton pump inhibitor)

Available
  • Glioblastoma
  • +13 more
  • (no location specified)
Jul 26, 2023

Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory, Advanced Solid Tumor Trial (TR115)

Not yet recruiting
  • Non-Hodgkin's Lymphoma, Relapsed
  • +2 more
  • (no location specified)
Dec 6, 2022

Solid Tumor, Non-Hodgkin Lymphoma Trial in Guangzhou, Shanghai (ADG106)

Active, not recruiting
  • Solid Tumor
  • Non-Hodgkin Lymphoma
  • Guangzhou, Guangdong, China
  • +1 more
Oct 15, 2022

Solid Tumor, Non-Hodgkin's Lymphoma Trial in China, Taiwan (ATG-019, ATG-019 + Niacin ER)

Recruiting
  • Solid Tumor, Non-Hodgkin's Lymphoma
  • Nanjing, Jiangsu, China
  • +7 more
Aug 11, 2022

Advanced Solid Tumor, Non Hodgkin Lymphoma Trial in Sarasota, Cincinnati, Nashville (BTX-A51)

Recruiting
  • Advanced Solid Tumor
  • Non Hodgkin Lymphoma
  • Sarasota, Florida
  • +2 more
Sep 8, 2022

Advanced Solid Tumor, Metastatic Solid Tumor, Mature B-cell Non-Hodgkin Lymphoma Trial in China (ATG-101)

Recruiting
  • Advanced Solid Tumor
  • +2 more
  • Jinan, China
  • +3 more
Aug 3, 2022

Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (ONM-501, Cemiplimab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • +13 more
  • (no location specified)
Aug 29, 2023

Solid Tumor, Non-Hodgkin Lymphoma Trial in Shanghai, Hangzhou (Gentulizumab)

Recruiting
  • Solid Tumor
  • Non-Hodgkin Lymphoma
  • Shanghai, Shanghai, China
  • +1 more
Jan 21, 2022

Solid Tumor, Non Hodgkin Lymphoma Trial in Guangzhou (ADG106 injection, PD-1 antibody injection)

Recruiting
  • Solid Tumor
  • Non Hodgkin Lymphoma
  • ADG106 injection
  • PD-1 antibody injection
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Jan 11, 2022

B-cell Non Hodgkin Lymphoma, Advanced Solid Tumor Trial in Edmonton, Toronto, Montréal (PCLX-001 treated)

Recruiting
  • B-cell Non Hodgkin Lymphoma
  • Advanced Solid Tumor
  • PCLX-001 treated
  • Edmonton, Alberta, Canada
  • +2 more
Feb 28, 2022

Lymphoma, Childhood Lymphoma, Solid Tumor Trial in Charlottesville (Genistein, Placebo)

Terminated
  • Lymphoma
  • +15 more
  • Charlottesville, Virginia
    University of Virginia
Feb 8, 2022

Solid Tumor, Adult, Non-hodgkin Lymphoma, Hodgkin Lymphoma Trial in India (AUR105)

Recruiting
  • Solid Tumor, Adult
  • +2 more
  • Vadodara, Gujarat, India
  • +6 more
Dec 14, 2022

Metastatic Cancer, Solid Tumor, Advanced Cancer Trial in Korea, Republic of, United States (Evorpacept (ALX148), Pembrolizumab,

Active, not recruiting
  • Metastatic Cancer
  • +3 more
  • Evorpacept (ALX148)
  • +5 more
  • Denver, Colorado
  • +9 more
Jul 20, 2022

Metastatic Melanoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Hodgkin Lymphoma Trial in

Active, not recruiting
Has Results
  • Metastatic Melanoma
  • +22 more
  • Ipilimumab
  • +3 more
  • Birmingham, Alabama
  • +24 more
Jan 19, 2023

Colorectal Carcinoma, Endometrial Carcinoma, Melanoma Trial in United States (Tegavivint)

Recruiting
  • Colorectal Carcinoma
  • +21 more
  • Dual X-ray Absorptiometry
  • +2 more
  • Birmingham, Alabama
  • +18 more
Jan 30, 2023

Advanced Solid Tumors, B-cell Non-Hodgkin Lymphomas Trial (ATG-031)

Not yet recruiting
  • Advanced Solid Tumors
  • B-cell Non-Hodgkin Lymphomas
  • (no location specified)
Aug 31, 2023

Advanced Solid Tumors, Relapsed/Refractory Non-Hodgkin Lymphoma, Relapsed/Refractory Multiple Myeloma Trial in Gyeonggi-do,

Recruiting
  • Advanced Solid Tumors
  • +2 more
  • GIC-102 (Allogeneic NK cells)
  • Gyeonggi-do, Korea, Republic of
  • +3 more
May 18, 2023

Small Cell Lung Cancer, Uveal Melanoma, Ovarian Clear Cell Carcinoma Trial in United States (PLX2853)

Completed
  • Small Cell Lung Cancer
  • +7 more
  • Scottsdale, Arizona
  • +4 more
Jul 20, 2022

Advanced or Metastatic Solid Tumors, Non-Hodgkin Lymphoma Trial in San Antonio (WTX-330)

Recruiting
  • Advanced or Metastatic Solid Tumors
  • Non-Hodgkin Lymphoma
  • San Antonio, Texas
    NEXT Oncology
Jan 6, 2023

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Hodgkin Lymphoma Trial in Madison (TCRaß+/CD19+ depleted Haploidentical

Recruiting
  • Acute Myeloid Leukemia
  • +10 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Mar 1, 2022

Tumors, Solid Tumor, Adult, Non-Hodgkin Lymphoma Trial in Worldwide (JNJ-64619178)

Active, not recruiting
  • Neoplasms
  • +3 more
  • Sarasota, Florida
  • +17 more
Jan 27, 2023

All Malignancies, Advanced Malignancies, Hematologic Malignancy Trial in Spain, United States (Tazemetostat, Itraconazole,

Active, not recruiting
  • All Malignancies
  • +11 more
  • Encinitas, California
  • +9 more
May 20, 2022

Renal Cell Carcinoma, Nasopharyngeal Carcinoma, Non Hodgkin Lymphoma Trial in United States (PRO1160)

Not yet recruiting
  • Renal Cell Carcinoma
  • +2 more
  • Detroit, Michigan
  • +4 more
Jan 31, 2023

Advanced Cancer, Advanced Solid Tumor, Tumor Malignant Trial in United Kingdom (Fosifloxuridine Nafalbenamide, Leucovorin,

Not yet recruiting
  • Advanced Cancer
  • +16 more
  • Fosifloxuridine Nafalbenamide
  • +3 more
  • Birmingham, United Kingdom
  • +3 more
Feb 1, 2023